Table 5.
Relationship between body composition and cardiometabolic risk markers
| Lower extremity fat/total fat | Appendicular lean mass/weight | |||||||
|---|---|---|---|---|---|---|---|---|
| Men | Women | Men | Women | |||||
| r | p | r | p | r | p | r | p | |
| Fasting glucose | 0.0002 | 1.0 | − 0.17 | 0.08*# | − 0.20 | 0.06*# | − 0.20 | 0.03 |
| 2-h glucose | − 0.16 | 0.2* | − 0.36 | 0.0002*# | − 0.08 | 0.5 | − 0.14 | 0.1 |
| Fasting insulin | − 0.26 | 0.05*# | − 0.40 | 0.0005*# | − 0.48 | < 0.0001*# | − 0.16 | 0.2 |
| HOMA-IR | − 0.24 | 0.06*# | − 0.40 | 0.0004*# | − 0.49 | < 0.0001*# | − 0.17 | 0.2 |
| Total cholesterol | − 0.09 | 0.4 | − 0.13 | 0.2 | 0.03 | 0.8 | − 0.21 | 0.02# |
| HDL cholesterol | 0.22 | 0.05* | 0.10 | 0.3 | 0.13 | 0.2 | 0.08 | 0.4* |
| LDL cholesterol | − 0.10 | 0.4 | − 0.09 | 0.4 | 0.07 | 0.5 | − 0.19 | 0.04# |
| Triglyceride level | − 0.20 | 0.08 | − 0.25 | 0.01*# | − 0.14 | 0.2 | − 0.24 | 0.009 |
| Apolipoprotein B (ApoB) | − 0.10 | 0.5 | − 0.25 | 0.03*# | 0.09 | 0.5 | − 0.21 | 0.06# |
| ApoB/LDL | − 0.20 | 0.1 | − 0.27 | 0.02* | − 0.13 | 0.3 | − 0.14 | 0.2 |
| hsCRP | − 0.08 | 0.6 | − 0.17 | 0.3 | − 0.40 | 0.003* | − 0.35 | 0.02 |
| Fibrinogen | − 0.29 | 0.02* | − 0.09 | 0.4 | − 0.41 | 0.001* | − 0.37 | 0.0008* |
Abbreviations: HOMA-IR homeostatic model assessment of insulin resistance, HDL high-density lipoprotein, LDL low-density lipoprotein, hsCRP high-sensitivity C-reactive protein
*Significant after controlling for age
#Significant after controlling for BMI